Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study

1. Grill, J.
2. Geoerger, B.
3. Gesner, L.
4. Perek, D.
5. Leblond, P.
6. Cañete, A.
7. Aerts, I.
8. Madero, L.
9. De Toledo Codina, J.S.
10. Verlooy, J.
11. Estlin, E.
12. Cisar, L.
13. Breazna, A.
14. Dorman, A.
15. Bailey, S.
16. Nicolin, G.
17. Grundy, R.G.
18. Hargrave, D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/NEUONC/NOT097 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus